Tuesday, March 16, 2010
Lilly receives exclusive rights to commercialize Acrux's testosterone solution
This kind of article makes me shake my head----yeah, let's get a patent out there on some new form of delivering testosterone to men who are deficient in the hormone---at I am sure a huge cost to the patient and/or their insurance companies. This kind of crap is part of what is driving up the cost of healthcare! For goodness sakes, how hard would it be for doctors to learn to correctly prescribe some bioidentical testosterone in cream form----I'll guarantee getting it through a compounding pharmacy, without the big profit for big Pharma, will make it a more cost efficient treatment.